Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery

Описание к видео Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery

Christopher J. Kane, MD, FACS, the Dean of Clinical Affairs at the University of California San Diego School of Medicine, and the CEO of the UC San Diego Health Physician Group, delivers an insightful presentation on surgery versus brachytherapy for intermediate and high-risk prostate cancer. He highlights the importance of accurately defining high-risk disease and presents his viewpoint that surgery is the optimal treatment for well-selected patients.

Комментарии

Информация по комментариям в разработке

Похожие видео